Convenient synthesis of sorafenib and its derivatives
L Zhang, W Xia, B Wang, Y Luo, W Lu
Index: Zhang, Lijuan; Xia, Wenpin; Wang, Bo; Luo, Yu; Lu, Wei Synthetic Communications, 2011 , vol. 41, # 21 p. 3140 - 3146
Full Text: HTML
Citation Number: 6
Abstract
View all references ] Sorafenib (compound 1a) is an oral multikinase inhibitor that blocks tumor cell proliferation and angiogenesis by targeting the serine/threonine kinases Raf-1/B-Raf and the tyrosine kinases (RTKs) of VEGFR -2/-3 and PDGFR-β. [ 2 2. (a) Huether , A. ; Hopfner , M. ; Baradari , V. ; Schuppan , D. ; Scherubl , H. Sorafenib alone or as combination therapy for growth control of cholangiocarcinoma . Biochem. Pharmacol. 2007 , 73 , 1308 – 1317 ; (b) ...
Related Articles:
Synthesis of unsymmetrical biaryl ureas from N-carbamoylimidazoles: kinetics and application
[Rawling, Tristan; McDonagh, Andrew M.; Tattam, Bruce; Murray, Michael Tetrahedron, 2012 , vol. 68, # 30 p. 6065 - 6070]
Synthesis of Aryl Urea Derivatives from Aryl Amines and Aryl Isocyanates
[Usharani; Bhujanga Rao; Reddy; Dubey Asian Journal of Chemistry, 2011 , vol. 23, # 4 p. 1802 - 1806]